Integral Health Asset Management, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1773206 New York, NY

Back to XENE Full portfolio

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,630,000

+$11,630,000 QoQ

Shares Held

200,000

Ownership

0.207%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Derivatives in XENE

reported options exposure · as of Mar 31, 2025

CallValue

CallShares

PutValue

$6,710,000

PutShares

200,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Integral Health Asset Management, LLC holds $1,255,592,830 across 56 Biotechnology names. XENE ranks #24 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	1,500,000	$245,280,000
2	RVMD	Revolution Medicines, Inc.	1,500,000	$145,875,000
3	CYTK	Cytokinetics Inc	1,600,000	$105,456,000
4	REGN	Regeneron Pharmaceuticals, Inc.	85,000	$65,674,400
5	VERA	Vera Therapeutics, Inc.	1,600,000	$64,368,000
6	ROIV	Roivant Sciences Ltd.	2,000,000	$55,400,000
7	RYTM	Rhythm Pharmaceuticals, Inc.	600,000	$52,182,000
8	EWTX	Edgewise Therapeutics, Inc.	1,600,000	$50,400,000

All Filings in XENE

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,630,000	200,000	0.0%	Shares	Sole	2026-05-15
2025-03-31	$6,710,000	200,000	+105.6%	Put	Sole	2025-05-15
2022-06-30	$2,959,288	97,281	—	Shares	Sole	2022-08-03
No filing history on record for this holder in this stock.